Evidence map›Paper›PMID 24493630›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2014

A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.

Habibul Ahsan, Jerry Halpern, Muhammad G Kibriya, Brandon L Pierce, Lin Tong, Eric Gamazon, Valerie McGuire, Anna Felberg, Jianxin Shi, Farzana Jasmine and 67 more

Abstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 2 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 2 syntheses or guidelines pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Characterization of Genetic Etiologic Factors for Pediatric Acute Lymphoblastic Leukemia in Large Childhood Cancer Survivorship Cohorts.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Expression ofGenes · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

77 authors at 2 institutions in 13 countries.

Habibul AhsanAuthors' Affiliations: Center for Cancer Epidemiology and Prevention; Departments of Health Studies, Medicine, and Human Genetics; Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; Department of Health Research and Policy, Stanford University School of Medicine; Stanford Cancer Institute, Stanford; Cancer Prevention Institute of California, Fremont; Department of Preventive Medicine, University of Southern California, Los Angeles; Stanford Cancer Institute, Palo Alto, California; Epidemiology and Genetics Research Program; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; Max Planck Institute of Psychiatry, Munich; Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; Foundation for Quality and Efficiency in Health Care, Cologne; Department of Cancer Epidemiology/Clinical Cancer Registry; Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; Department of Psychiatry, University of Mainz, Mainz, Germany; Samuel Lunenfeld Research Institute; Zane Cohen Cen
Jerry Halpern
Muhammad G Kibriya
Brandon L Pierce
Lin Tong
Eric Gamazon
Valerie McGuire
Anna Felberg
Jianxin Shi
Farzana Jasmine
Shantanu Roy
Rachelle Brutus
Maria Argos
Stephanie Melkonian
Jenny Chang-Claude
Irene Andrulis
John L Hopper
Esther M John
Kathi Malone
Giske Ursin
Marilie D Gammon
Duncan C Thomas
Daniela Seminara
Graham Casey
Julia A Knight
Melissa C Southey
Graham G Giles
Regina M Santella
Eunjung Lee
David Conti
David Duggan
Steve Gallinger
Robert Haile
Mark Jenkins
Noralane M Lindor
Polly Newcomb
Kyriaki Michailidou
Carmel Apicella
Daniel J Park
Julian Peto
Olivia Fletcher
Isabel dos Santos Silva
Mark Lathrop
David J Hunter
Stephen J Chanock
Alfons Meindl
Rita K Schmutzler
Bertram Müller-Myhsok
Magdalena Lochmann
Lars Beckmann
Rebecca Hein
Enes Makalic
Daniel F Schmidt
Quang Minh Bui
Jennifer Stone
Dieter Flesch-Janys
Norbert Dahmen
Heli Nevanlinna
Kristiina Aittomäki
Carl Blomqvist
Per Hall
Kamila Czene
Astrid Irwanto
Jianjun Liu
Nazneen Rahman
Clare Turnbull
Familial Breast Cancer Study
Alison M Dunning
Paul Pharoah
Quinten Waisfisz
Hanne Meijers-Heijboer
Andre G Uitterlinden
Fernando Rivadeneira
Dan Nicolae
Douglas F Easton
Nancy J Cox
Alice S Whittemore
University of North Carolina at Chapel Hill · USCancer Prevention Institute of California · US

Funding

True Metal fac coreP30ES009089 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MATTHEW S PERZANOWSKI · 1998 to 2026
$44.7M
Northern California Cooperative Family Registry for Breast CancerU01CA069417 · NCI · NORTHERN CALIFORNIA CANCER CENTER · PI JOHN, ESTHER M. · 1995 to 2010
$22.4M
USC Consortium:Colorectal Cancer Family RegistryU01CA074799 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HAILE, ROBERT WILLIAM · 1997 to 2008
$20.4M
Re-Engineering Translational Research at the University of ChicagoUL1TR000430 · NCATS · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2012 to 2016
$20.2M
Breast Cancer Family Registry CohortUM1CA164920 · NCI · CANCER PREVENTION INSTIT OF CALIFORNIA · PI ANDRULIS, IRENE, BUYS, SAUNDRA S · 2012 to 2017
$12.7M
Colon Cancer Family Registry CohortUM1CA167551 · NCI · STANFORD UNIVERSITY · PI HAILE, ROBERT WILLIAM, JENKINS, MARK A · 2013 to 2017
$11.3M
Epidemiologic StudiesU19CA148065 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI AHSAN, HABIBUL, BRUGGE, JOAN SIEFERT · 2010 to 2014
$10.6M
ONTARIO REGISTRY FOR STUDIES OF FAMILIAL BREAST CANCERU01CA069467 · NCI · CANCER CARE ONTARIO · PI ANDRULIS, IRENE L. · 1995 to 2010
$10.4M
Statistical Methods for Genetic EpidemiologyR01CA094069 · NCI · STANFORD UNIVERSITY · PI WHITTEMORE, ALICE · 2002 to 2016
$7.7M
The Colon Cancer Family Registry: USC ConsortiumU24CA074799 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HAILE, ROBERT WILLIAM · 2008 to 2011
$7.6M
Genomic Wide Association Study of Colorectal CancerU01CA122839 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI CASEY, GRAHAM · 2006 to 2010
$7.3M
Genomewide association in early-onset breast cancerU01CA122171 · NCI · UNIVERSITY OF CHICAGO · PI AHSAN, HABIBUL · 2006 to 2010
$7.2M
Cancer Research UK 10118Cancer Research UK 10124Cancer Research UK 11022Cancer Research UK 15106Cancer Research UK 16561Cancer Research UK 16563Cancer Research UK 16565NCATS NIH HHS UL1 TR000430NCI NIH HHS CA-06-503NCI NIH HHS CA-95-011NCI NIH HHS R01 CA094069NCI NIH HHS R01CA094069NCI NIH HHS RC1 CA145506NCI NIH HHS RC1CA145506NCI NIH HHS U01 CA069417NCI NIH HHS U01 CA069467NCI NIH HHS U01 CA069638NCI NIH HHS U01 CA074799NCI NIH HHS U01 CA122171NCI NIH HHS U01CA122171NCI NIH HHS U01 CA122839NCI NIH HHS U01 CA69417NCI NIH HHS U01CA69467NCI NIH HHS U01CA69638NCI NIH HHS U19 CA148065NCI NIH HHS U19CA148065NCI NIH HHS U24 CA074799NCI NIH HHS UM1 CA164920NCI NIH HHS UM1 CA167551NIEHS NIH HHS P30 ES009089NIMH NIH HHS R01 MH090937NIMH NIH HHS R01 MH101820
6 · The paper itself

Abstract

Early-onset breast cancer (EOBC) causes substantial loss of life and productivity, creating a major burden among women worldwide. We analyzed 1,265,548 Hapmap3 single-nucleotide polymorphisms (SNP) among a discovery set of 3,523 EOBC incident cases and 2,702 population control women ages ≤ 51 years. The SNPs with smallest P values were examined in a replication set of 3,470 EOBC cases and 5,475 control women. We also tested EOBC association with 19,684 genes by annotating each gene with putative functional SNPs, and then combining their P values to obtain a gene-based P value. We examined the gene with smallest P value for replication in 1,145 breast cancer cases and 1,142 control women. The combined discovery and replication sets identified 72 new SNPs associated with EOBC (P < 4 × 10(-8)) located in six genomic regions previously reported to contain SNPs associated largely with later-onset breast cancer (LOBC). SNP rs2229882 and 10 other SNPs on chromosome 5q11.2 remained associated (P < 6 × 10(-4)) after adjustment for the strongest published SNPs in the region. Thirty-two of the 82 currently known LOBC SNPs were associated with EOBC (P < 0.05). Low power is likely responsible for the remaining 50 unassociated known LOBC SNPs. The gene-based analysis identified an association between breast cancer and the phosphofructokinase-muscle (PFKM) gene on chromosome 12q13.11 that met the genome-wide gene-based threshold of 2.5 × 10(-6). In conclusion, EOBC and LOBC seem to have similar genetic etiologies; the 5q11.2 region may contain multiple distinct breast cancer loci; and the PFKM gene region is worthy of further investigation. These findings should enhance our understanding of the etiology of breast cancer.

Indexed as

Biomarkers, TumorBreast NeoplasmsCase-Control StudiesFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansMiddle AgedPhosphofructokinase-1, Muscle TypePolymorphism, Single NucleotideBiomarkers, TumorPFKM protein, humanPhosphofructokinase-1, Muscle Type

Identifiers

PMID24493630
PMCPMC3990360
OpenAlexW2156073112

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.